Curis Inc stock is traded at $0.9065, with a volume of 2,464,495. It is up +6.65% in the last 24 hours and up +21.03% over the past month. Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Previous Close:
$0.85
Open:
$0.7984
24h Volume:
2,464,495
Relative Volume:
0.10
Market Cap:
$2.20M
Revenue:
$7.06M
Net Income/Loss:
-$21.17M
P/E Ratio:
-
EPS:
-$23.88
Net Cash Flow:
-$28.95M
1W Performance:
+51.08%
1M Performance:
+21.03%
6M Performance:
-92.65%
1Y Performance:
-96.90%
1-Day Range:
$0.7601$0.947
1-Week Range:
$0.573$1.60
52-Week Range:
$0.325$29.80
Curis Inc Stock (CRIS) Company Profile
Name
Curis IncSector
HealthcareIndustry
BiotechnologyPhone
617-503-6500Address
128 SPRING STREET, LEXINGTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS